New blood-clot drugs may add to gastrointestinal bleeding risk

07/22/2013 | PhysiciansBriefing.com

Gastrointestinal bleeding is more likely to occur with newer oral anticoagulants than with standard treatment, according to an analysis in the journal Gastroenterology. Researchers analyzed data on 151,578 patients who participated in 43 randomized, controlled studies and found that the risk was greatest for those undergoing therapy for venous thrombosis and acute coronary syndrome. "The current evidence, however, is based on a highly selected patient group with a low bleeding risk, disallowing a true reflection of future patients in daily clinical practice," researchers wrote.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations